A detailed history of Blair William & CO transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Blair William & CO holds 425,913 shares of PRCT stock, worth $32.4 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
425,913
Previous 420,305 1.33%
Holding current value
$32.4 Million
Previous $25.7 Million 32.88%
% of portfolio
0.1%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$56.31 - $84.99 $315,786 - $476,623
5,608 Added 1.33%
425,913 $34.1 Million
Q2 2024

Aug 12, 2024

SELL
$45.73 - $69.19 $433,886 - $656,474
-9,488 Reduced 2.21%
420,305 $25.7 Million
Q1 2024

May 09, 2024

BUY
$40.38 - $50.75 $17.4 Million - $21.8 Million
429,793 New
429,793 $21.2 Million
Q2 2023

Aug 11, 2023

BUY
$26.7 - $37.02 $288,894 - $400,556
10,820 New
10,820 $382,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.39B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.